NCT05922241Completed
Comparative Effects of Costophrenic Assisted Cough and Anterior Chest Compression Technique in COPD Patients
Comparative Effects of Costophrenic Assisted Cough and Anterior Chest Compression Technique on Sputum Diary, Oxygen Saturation, Expiratory Flow Rate, and Dyspnea in Patients With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 27 Dec 2023
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. In Costophrenic assist, the therapist gives a quick stretch to the diaphragm and intercostals with repetitions. The patientt holds air in the lungs. As the patient gets ready to cough, the therapist performs a diaphragmatic assist. In Anterior chest compression: the therapist places one arm across the patient's pectorals and the other parallel to it. After the patient takes a maximal breath, the therapist pushes down to help the patient cough. The greatest force is applied through the lower chest during expulsion. A total 34 patients will be taken. 2 groups will be created to apply intervention. After signing consent form, 17 patients in group A will be given costophrenic assist technique and 17 patients in group B will be given anterior chest compression technique. Baseline treatment given to both groups will include percussion and tapping. The data collected will then be analyzed using IBM SPSS version 25
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 6 Jun 2023
- Start date
- 15 Jun 2023
- Primary completion date
- 15 Sept 2023
- Lead sponsor
- Riphah International University
- Diseases
- COPD
- NCT number
- NCT05922241
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 15 Jun 2023 to the primary completion date, 15 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non Covid
- Neurogenic Disease
Other
- Tachycardia
- Tachypnea
- Cardiovascular Pathology
- Myopathy
Who the study is looking for
- Stable Patients
- Mild to Moderate Patients of COPD according to gold criteria
- Decreased O2 Saturation Levels
- Immobilized Mucus
Age in the registry: 40 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sheikh Zayed Hospital, Coordinator of this site? Confirm its status | Rahim Yar Khan | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.